(Total Views: 182)
Posted On: 03/20/2018 11:39:53 AM
Post# of 99243
$IVST announced it has signed a Letter of Intent to acquire a 20% stake in StemVax LLC. StemVax is a Translational Biotechnology Company that is currently developing a cancer vaccine therapy that enhances the patient’s immune response against brain tumors. https://finance.yahoo.com/news/innovest-globa...00658.html
(0)
(0)
